Biostar Pharmaceuticals, Inc.
BSPM · OTC
12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,698 | -$25,113 | $4,848 | $809 |
| Dep. & Amort. | $1,143 | $2,320 | $3,086 | $2,787 |
| Deferred Tax | $2,653 | $1,333 | -$4,285 | $981 |
| Stock-Based Comp. | $0 | $0 | $2,021 | $757 |
| Change in WC | $7,308 | $5,348 | -$6,076 | $2,236 |
| Other Non-Cash | -$227 | $4,021 | $3,716 | $1,339 |
| Operating Cash Flow | $4,913 | $5,877 | $3,311 | $8,909 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$59 | -$2,869 | -$982 |
| Net Acquisitions | -$6,378 | -$8,122 | -$4,881 | -$3,875 |
| Inv. Purchases | $0 | -$804 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $804 | $0 | $0 |
| Other Inv. Act. | -$6,378 | $804 | -$1,127 | $646 |
| Investing Cash Flow | -$6,378 | -$7,378 | -$8,878 | -$4,211 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$278 | -$161 | $3,092 | -$4,843 |
| Stock Issued | $1,690 | $0 | $3,863 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | -$1,614 |
| Financing Cash Flow | $1,411 | -$161 | $6,954 | -$6,458 |
| Forex Effect | $189 | $15 | $218 | $80 |
| Net Chg. in Cash | $134 | -$1,646 | $1,605 | -$1,679 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $39 | $1,685 | $80 | $1,759 |
| End Cash | $173 | $39 | $1,685 | $80 |
| Free Cash Flow | $4,913 | $5,818 | $441 | $7,927 |